Begin main content


Last Updated: September 25, 2012
Result type: Reports
Project Number: SR0288
Product Line: Common Drug Review

Generic Name: Apixaban

Brand Name: Eliquis

Manufacturer: Bristol-Myers Squibb Canada and Pfizer Canada Inc. Alliance

Indications: Thromboembolic events prevention, (atrial fibrillation)

Submission Type: New Indication

Project Status: Complete

Date Recommendation Issued: March 20, 2013

Recommendation Type: List with clinical criteria and/or conditions